These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
129 related articles for article (PubMed ID: 38180299)
1. TGFB1I1 promotes cell proliferation and migration in urothelial carcinoma. Liang PI; Wei YC; Chen HD; Ma YC; Ke HL; Chien CC; Chuang HW Kaohsiung J Med Sci; 2024 Mar; 40(3):269-279. PubMed ID: 38180299 [TBL] [Abstract][Full Text] [Related]
2. IGFBP-5 overexpression as a poor prognostic factor in patients with urothelial carcinomas of upper urinary tracts and urinary bladder. Liang PI; Wang YH; Wu TF; Wu WR; Liao AC; Shen KH; Hsing CH; Shiue YL; Huang HY; Hsu HP; Chen LT; Lin CY; Tai C; Wu JY; Li CF J Clin Pathol; 2013 Jul; 66(7):573-82. PubMed ID: 23539739 [TBL] [Abstract][Full Text] [Related]
3. High expression of Chitinase 3-like-1 is an unfavorable prognostic factor in urothelial carcinoma of upper urinary tract and urinary bladder. Lee YE; Chan TC; Tian YF; Liang PI; Shiue YL; Chen YS; He HL Urol Oncol; 2019 May; 37(5):299.e7-299.e18. PubMed ID: 30660494 [TBL] [Abstract][Full Text] [Related]
4. Upregulation of dihydropyrimidinase-like 3 (DPYSL3) protein predicts poor prognosis in urothelial carcinoma. Liang PI; Lai HY; Chan TC; Li WM; Hsing CH; Huang SK; Hsieh KL; Tseng WH; Chen TJ; Li WS; Chen HD; Kuo YH; Li CF BMC Cancer; 2023 Jun; 23(1):599. PubMed ID: 37380971 [TBL] [Abstract][Full Text] [Related]
5. Sulfatase-1 overexpression indicates poor prognosis in urothelial carcinoma of the urinary bladder and upper tract. Lee HY; Yeh BW; Chan TC; Yang KF; Li WM; Huang CN; Ke HL; Li CC; Yeh HC; Liang PI; Shiue YL; Wu WJ; Li CF Oncotarget; 2017 Jul; 8(29):47216-47229. PubMed ID: 28525382 [TBL] [Abstract][Full Text] [Related]
6. MCM10 overexpression implicates adverse prognosis in urothelial carcinoma. Li WM; Huang CN; Ke HL; Li CC; Wei YC; Yeh HC; Chang LL; Huang CH; Liang PI; Yeh BW; Chan TC; Li CF; Wu WJ Oncotarget; 2016 Nov; 7(47):77777-77792. PubMed ID: 27780919 [TBL] [Abstract][Full Text] [Related]
7. INHBA overexpression indicates poor prognosis in urothelial carcinoma of urinary bladder and upper tract. Lee HY; Li CC; Huang CN; Li WM; Yeh HC; Ke HL; Yang KF; Liang PI; Li CF; Wu WJ J Surg Oncol; 2015 Mar; 111(4):414-22. PubMed ID: 25488476 [TBL] [Abstract][Full Text] [Related]
8. Clinical utility and concordance of upper urinary tract cytology and biopsy in predicting clinicopathological features of upper urinary tract urothelial carcinoma. Simon CT; Skala SL; Weizer AZ; Ambani SN; Chinnaiyan AM; Palapattu G; Hafez K; Magers MJ; Kaffenberger SD; Spratt DE; Montgomery JS; Morgan TM; Udager AM; Lew M; Mehra R Hum Pathol; 2019 Apr; 86():76-84. PubMed ID: 30537495 [TBL] [Abstract][Full Text] [Related]
9. The autocrine glycosylated-GREM1 interacts with TGFB1 to suppress TGFβ/BMP/SMAD-mediated EMT partially by inhibiting MYL9 transactivation in urinary carcinoma. Chan TC; Pan CT; Hsieh HY; Vejvisithsakul PP; Wei RJ; Yeh BW; Wu WJ; Chen LR; Shiao MS; Li CF; Shiue YL Cell Oncol (Dordr); 2023 Aug; 46(4):933-951. PubMed ID: 36920729 [TBL] [Abstract][Full Text] [Related]
10. Downregulation of RNF128 Predicts Progression and Poor Prognosis in Patients with Urothelial Carcinoma of the Upper Tract and Urinary Bladder. Lee YY; Wang CT; Huang SK; Wu WJ; Huang CN; Li CC; Chan TC; Liang PI; Hsing CH; Li CF J Cancer; 2016; 7(15):2187-2196. PubMed ID: 27994654 [No Abstract] [Full Text] [Related]
11. GPX2 underexpression indicates poor prognosis in patients with urothelial carcinomas of the upper urinary tract and urinary bladder. Chang IW; Lin VC; Hung CH; Wang HP; Lin YY; Wu WJ; Huang CN; Li CC; Li WM; Wu JY; Li CF World J Urol; 2015 Nov; 33(11):1777-89. PubMed ID: 25813210 [TBL] [Abstract][Full Text] [Related]
12. Differential expression of SLITRK6 gene as a potential therapeutic target for urothelial carcinoma in particular upper tract cancer. Mir MA; Pandith AA; Mansoor S; Baba SM; Makhdoomi R; Ain QU; Anwar I; Para SA; Bhat AH; Koul AM; Manzoor U; Khan I; Beg A; Wani MS Gene; 2023 Aug; 878():147583. PubMed ID: 37353040 [TBL] [Abstract][Full Text] [Related]
13. Low expression of ZSCAN4 predicts unfavorable outcome in urothelial carcinoma of upper urinary tract and urinary bladder. He HL; Lai HY; Chan TC; Hsing CH; Huang SK; Hsieh KL; Chen TJ; Li WS; Kuo YH; Shiue YL; Li CF World J Surg Oncol; 2023 Feb; 21(1):62. PubMed ID: 36841776 [TBL] [Abstract][Full Text] [Related]
14. Downregulation of CRTAC1 in Urothelial Carcinoma Promotes Tumor Aggressiveness and Confers Poor Prognosis. Li WM; Chan TC; Wei YC; Li CF; Ke HL; Wu WJ; Hsu CC; Wang SC; Yeh CF Front Biosci (Landmark Ed); 2023 Sep; 28(9):217. PubMed ID: 37796703 [TBL] [Abstract][Full Text] [Related]
15. Distinct patterns and behaviour of urothelial carcinoma with respect to anatomical location: how molecular biomarkers can augment clinico-pathological predictors in upper urinary tract tumours. Yates DR; Catto JW World J Urol; 2013 Feb; 31(1):21-9. PubMed ID: 22986906 [TBL] [Abstract][Full Text] [Related]
16. DNA Hypomethylation Is Associated with the Overexpression of INHBA in Upper Tract Urothelial Carcinoma. Kao CC; Chang YL; Liu HY; Wu ST; Meng E; Cha TL; Sun GH; Yu DS; Luo HL Int J Mol Sci; 2022 Feb; 23(4):. PubMed ID: 35216189 [TBL] [Abstract][Full Text] [Related]
17. Comprehensive Genomic Profiling of Upper-tract and Bladder Urothelial Carcinoma. Necchi A; Madison R; Pal SK; Ross JS; Agarwal N; Sonpavde G; Joshi M; Yin M; Miller VA; Grivas P; Chung JH; Ali SM Eur Urol Focus; 2021 Nov; 7(6):1339-1346. PubMed ID: 32861617 [TBL] [Abstract][Full Text] [Related]
18. Second-line Pembrolizumab for Metastatic Urothelial Carcinoma: Differences in Treatment Outcomes According to the Primary Site. Nishiyama N; Kita Y; Ito K; Kato M; Hatakeyama S; Matsushita Y; Naito S; Miyake M; Nakanishi S; Kato Y; Shibuya T; Hayashi T; Yasumoto H; Yoshida T; Uemura M; Taoka R; Nishiyama H; Kobayashi T; Kitamura H; Anticancer Res; 2023 Nov; 43(11):5041-5050. PubMed ID: 37909969 [TBL] [Abstract][Full Text] [Related]
19. Upper urinary tract urothelial carcinoma in eastern Taiwan: high proportion among all urothelial carcinomas and correlation with chronic kidney disease. Chen CY; Liao YM; Tsai WM; Kuo HC J Formos Med Assoc; 2007 Dec; 106(12):992-8. PubMed ID: 18194904 [TBL] [Abstract][Full Text] [Related]
20. Prognostic significance of non-muscle-invasive bladder tumor history in patients with upper urinary tract urothelial carcinoma. Milojevic B; Djokic M; Sipetic-Grujicic S; Grozdic Milojevic I; Vuksanovic A; Nikic P; Vukovic I; Djordjevic D; Bumbasirevic U; Tulic C Urol Oncol; 2013 Nov; 31(8):1615-20. PubMed ID: 22521771 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]